SAFETY OF A NEW SEDDS FORMULATION OF ORAL TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN: DATA FROM TWO PHASE 3 TRIALS WITH DIFFERENT DOSE-TITRATION ALGORITHMS

被引：0

作者：

Swerdloff, R. S. ^{[1
]}

Sulameh, W. ^{[2
]}

Dohs, A.

Faulknel, S. ^{[2
]}

Dudley, R. ^{[2
]}

Flippo, G. ^{[3
]}

Kaminetsky, J. ^{[4
]}

Armory, J. ^{[5
]}

Honig, S. H. ^{[6
]}

Danoff, T. ^{[2
]}

Wang, C. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Los Angeles, CA 90024 USA

[2] Clarus Therapeut, Northbrook, IL USA

[3] Alabama Clin Theraput, Birmingham, AL USA

[4] Univ Urrol Assoc, New York, NY USA

[5] Univ Washington, Seattle, WA 98195 USA

[6] Yale Univ, New Haven, CT 06520 USA

来源：

JOURNAL OF SEXUAL MEDICINE | 2015年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

136

引用

页码：150 / 150

页数：1

共 19 条

[11] Meaningful and Sustained Improvements of Weight and Waist Circumference in Hypogonadal Men on Long-Term Treatment with Testosterone Undecanoate (TU) Injections Are Independent of Age: Observational Data from Two Registry Studies
Yassin, Aksam A.
Haider, Ahmad
Doros, Gheorghe
Traish, Abdulmaged M.
Saad, Farid
ENDOCRINE REVIEWS, 2014, 35 (03)
[12] Improvement of Metabolic Syndrome (MetS) Parameters in 362 Obese Hypogonadal Men upon Long-Term Treatment with Testosterone Undecanoate (TU) Injections: Observational Data from Two Registry Studies
Haider, Ahmad
Yassin, Aksam A.
Doros, Gheorghe
Traish, Abdulmaged M.
Saad, Farid
ENDOCRINE REVIEWS, 2014, 35 (03)
[13] IMPROVEMENT OF METABOLIC SYNDROME (METS) PARAMETERS IN 362 OBESE HYPOGONADAL MEN UPON LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU) INJECTIONS: OBSERVATIONAL DATA FROM TWO REGISTRY STUDIES
Saad, F.
Haider, A.
Yassin, A.
Doros, G.
Traish, A.
JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 77 - 77
[14] Reductions of Weight and Waist Size in 362 Hypogonadal Men with Obesity Grades I to III Under Long-Term Treatment with Testosterone Undecanoate (TU): Observational Data from Two Registry Studies
Haider, Ahmad
Yassin, Aksam A.
Doros, Gheorghe
Traish, Abdulmaged M.
Saad, Farid
ENDOCRINE REVIEWS, 2014, 35 (03)
[15] WEIGHT LOSS AND REDUCTION OF WAIST SIZE IN 362 HYPOGONADAL MEN WITH OBESITY GRADES I TO III UPON LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU): OBSERVATIONAL DATA FROM TWO REGISTRY STUDIES
Saad, F.
Haider, A.
Yassin, A.
Doros, G.
Traish, A.
JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 54 - 55
[16] Weight loss and reduction of waist size in 362 hypogonadal men with obesity grades I to III upon long-term treatment with testosterone undecanoate (TU): observational data from two registry studies
Saad, F.
Haider, A.
Yassin, A.
Doros, G.
Traish, A.
EUROPEAN HEART JOURNAL, 2014, 35 : 905 - 905
[17] LONG-TERM SAFETY AND TOLERABILITY OF ORAL TESTOSTERONE (LPCN 1021) IN HYPOGONADAL MEN: RESULTS FROM THE 52-WEEK PHASE 3 STUDY
Khera, Mohit
Wang, Christina
Kaminetsky, Jed
Miner, Martin
Dobs, Adrian
Deiconte, Anthony
Chidambaram, Nachiappan
Nachaegari, Satish
Patel, Mahesh
JOURNAL OF UROLOGY, 2016, 195 (04): : E1187 - E1188
[18] Safety and tolerability of fentanyl sublingual spray during the titration phase of two phase 3 clinical trials: results from pooled data
Rauck, R.
Stearns, L.
Forman, N.
Parikh, N.
Dillaha, L.
JOURNAL OF PAIN, 2014, 15 (04): : S67 - S67
[19] Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea Two Phase 3 Randomized Clinical Trials
Bhatia, Neal
Del Rosso, James
Gold, Linda Stein
Lain, Edward
Draelos, Zoe Diana
Sidgiddi, Srinivas
JAMA DERMATOLOGY, 2025,

← 1 2 →